Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Compare volatility and returns in retirement index funds to strike a balance between potential growth and risk control for sustainable withdrawals.
24,638 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Fundstrat co-founder Tom Lee points to the ETH/BTC ratio as a sign of a potential leadership shift in crypto, suggest...
Could SpaceX expand from rockets to handheld devices? This article examines the idea of spacex planning make smartpho...
Sandisk recently surged after spinning out from Western Digital, trading well above its 52-week low. This deep dive w...
As Anthropic eyes an IPO, a potential $1.2 trillion valuation could ripple through AI stocks. This piece breaks down ...
Cathie Wood’s big bet on CRISPR Therapeutics signals more than faith in gene editing. This article digs into the unde...
Broadcom stock has stalled in a sideways move as AI infrastructure spending stays in focus. Analysts weigh a cautious...
Analysts publish a multi-year outlook for filecoin as decentralized storage expands. The latest filecoin (fil) price ...
As remitly gears up for 2025, investors should focus on growth drivers, margin potential, and the risks that could sh...
A Supreme Court ruling is reshaping expectations for U.S. tariff policy as levies near their July expiry. Morgan Stan...
Mullen’s share path remains highly uncertain as the EV market shifts and capital needs loom. This report maps potenti...
Quantum computing is still in its early innings, and Rigetti Computing sits at a pivotal crossroads. This article bre...